Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sankyo's new blood glucose-lowering agents described in recent patent

Nov. 13, 2000

Fujisawa continuing zenarestat development in Japan

Nov. 13, 2000

Structural Bioinformatics reports small-molecule PTP1B inhibitors

Nov. 13, 2000

Novartis and Noven enter marketing agreement for transdermal HRT

Nov. 13, 2000

Selective ERbeta receptor agonists synthesized by Akzo Nobel

Nov. 10, 2000

Akzo Nobel claims new series of orally active androgens

Nov. 10, 2000

Neurocrine Biosciences to begin U.S. trials with altered peptide ligand for type 1 diabetes

Nov. 10, 2000

Potential new treatments for bone and cartilage disorders revealed by SB scientists

Nov. 9, 2000

Pfizer patents fructose-lowering sorbitol dehydrogenase inhibitors

Nov. 9, 2000

Forbes Medi-Tech's FM-VP4 inhibits cholesterol absorption in preclinical trials

Nov. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...